Dioxaphetyl butyrate

Dioxaphetyl butyrate
Systematic (IUPAC) name
Ethyl 4-morpholin-4-yl-2,2-di(phenyl)butanoate
Clinical data
  • AU: Prohibited (S9)
  • US: C
Oral, Other ROA Unknown
Identifiers
467-86-7 Yes
None
PubChem CID 48194
UNII G751H98FY4 
Synonyms Amidalgon, Spasmoxal
Chemical data
Formula C22H27NO3
353.45 g/mol
  (what is this?)  (verify)

Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.

It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.

In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregrate manufacturing quota of zero.

References